Bill

Bill > HR4733


US HR4733

Opioids and STOP Pain Initiative Act


summary

Introduced
12/21/2017
In Committee
01/03/2018
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

115th Congress

Bill Summary

Opioids and STOP Pain Initiative Act This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including: understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016; improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and supporting the Federal Pain Research Strategy. NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

AI Summary

This bill establishes and provides $5 billion in funding for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support research on understanding pain, developing new therapies and alternatives to opioids for chronic pain treatment, improving medication-assisted treatment and overdose reversal treatments, and other elements of the Federal Pain Research Strategy. The bill also directs NIH to establish a Pain Therapy Screening Program to award grants for developing new pre-clinical models for pain disorders and screening new drug, device, or other therapies. The funding is designated as emergency spending and the bill allows the Secretary of Health and Human Services to accept related industry donations.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (29)

Last Action

Referred to the Subcommittee on Health. (on 01/03/2018)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...